6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
15m ago	National Fuel Reports Second Quarter Fiscal 2026 Earnings
15m ago	EquipmentShare to Present at the Oppenheimer 21st Annual Industrial Growth Conference
15m ago	Clearway Energy, Inc. Announces Results of 2026 Annual Meeting of Stockholders
16m ago	Wesley N. Slagle Elected to the RPC, Inc. Board of Directors
16m ago	22nd Century Group Shares 2026 Vision for VLN® Product Growth and Tobacco Harm Reduction Leadership

About

Cytomx Therapeutics Inc (NASDAQ:CTMX) — investor relations, events, news, and company updates on 6ix.

Latest News

CytomX Therapeutics Announces Pricing of $250 Million Offering of Common Stock and Pre-Funded Warrants

CytomX Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

CytomX Therapeutics Announces 2025 Financial Results and Provides Business Update

CytomX Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on March 16, 2026

CytomX Therapeutics to Present at Upcoming February Conferences

Financials

Revenue

$76.2 M

Market Cap

$985.77 M

EPS

-0.15

Community Chat

Ask AI